Exelixis, Inc. (EXEL)
Stay on top of your portfolio with a custom homepage and newsletter. Start today!
Stock Price Variations Over Last 10 Days
Exelixis Announces Initiation of CONTACT-03 Phase 3 Pivotal Trial of Cabozantinib in Combination With Atezolizumab in Previously Treated Metastatic Renal Cell Carcinoma
Jul 22, 2020